Table Of Contents:
1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	30
2.4 Emerging Opportunities and Market Trends	33
2.5 Porter’s Fiver Forces Analysis	37
3 Segmentation of North America Market by Molecule Type	41
3.1 Market Overview by Molecule Type	41
3.2 Small Molecule	43
3.3 Large Molecule	44
4 Segmentation of North America Market by Drug Class	45
4.1 Market Overview by Drug Class	45
4.2 Monoclonal Antibodies (mAbs)	47
4.3 Immunoglobulin	48
4.4 Insulin	49
4.5 Vaccines	50
4.6 Cytokines	51
4.7 Peptide Hormone	52
4.8 Blood Factors	53
4.9 Other Drug Classes	54
5 Segmentation of North America Market by Delivery	55
5.1 Market Overview by Delivery	55
5.2 Pre-filled Syringe	57
5.3 Infusions	58
5.4 Other Deliveries	59
6 Segmentation of North America Market by Application	60
6.1 Market Overview by Application	60
6.2 Oncology	62
6.3 Infectious Diseases	63
6.4 Autoimmune Diseases	64
6.5 Cardiovascular Diseases	65
6.6 Pain	66
6.7 Neurology	67
6.8 Other Applications	68
7 Segmentation of North America Market by Distribution Channel	69
7.1 Market Overview by Distribution Channel	69
7.2 Hospital Pharmacy	71
7.3 Retail Pharmacy	72
7.4 E-Commerce	73
8 North America Market 2019-2030 by Country	74
8.1 Overview of North America Market	74
8.2 U.S.	77
8.3 Canada	80
8.4 Mexico	82
9 Competitive Landscape	84
9.1 Overview of Key Vendors	84
9.2 New Product Launch, Partnership, Investment, and M&A	87
9.3 Company Profiles	88
Amgen Inc.	88
Baxter International Inc.	90
Eli Lilly and Company	91
Gilead Sciences Inc.	92
GlaxoSmithKline PLC	93
Johnson & Johnson	94
Merck & Co. Inc.	95
Moderna, Inc.	96
Novartis AG	97
Novo Nordisk AS	98
Pfizer Inc.	99
Sanofi SA	100
Teva Pharmaceuticals Industries Ltd.	101
RELATED REPORTS	102

List Of Tables:

Table 1.  Snapshot of North America Injectable Drugs Market in Balanced Perspective, 2019-2030	17
Table 2. Growth Rate of World GDP, 2020-2022	21
Table 3. World Health Spending by Region, $ bn, 2013-2020	29
Table 4.  Main Product Trends and Market Opportunities in North America Injectable Drugs Market	33
Table 5. North America Injectable Drugs Market by Molecule Type, 2019-2030, $ bn	41
Table 6. North America Injectable Drugs Market by Drug Class, 2019-2030, $ bn	45
Table 7. North America Injectable Drugs Market by Delivery, 2019-2030, $ bn	55
Table 8. North America Injectable Drugs Market by Application, 2019-2030, $ bn	60
Table 9. North America Injectable Drugs Market by Distribution Channel, 2019-2030, $ bn	69
Table 10. North America Injectable Drugs Market by Country, 2019-2030, $ bn	75
Table 11. U.S. Injectable Drugs Market by Molecule Type, 2019-2030, $ bn	79
Table 12. U.S. Injectable Drugs Market by Drug Class, 2019-2030, $ bn	79
Table 13. U.S. Injectable Drugs Market by Application, 2019-2030, $ bn	79
Table 14. Canada Injectable Drugs Market by Molecule Type, 2019-2030, $ bn	81
Table 15. Canada Injectable Drugs Market by Drug Class, 2019-2030, $ bn	81
Table 16. Canada Injectable Drugs Market by Application, 2019-2030, $ bn	81
Table 17. Mexico Injectable Drugs Market by Molecule Type, 2019-2030, $ bn	83
Table 18. Mexico Injectable Drugs Market by Drug Class, 2019-2030, $ bn	83
Table 19. Mexico Injectable Drugs Market by Application, 2019-2030, $ bn	83
Table 20. Amgen Inc.: Company Snapshot	88
Table 21. Amgen Inc.: Business Segmentation	88
Table 22. Amgen Inc.: Product Portfolio	89
Table 23. Amgen Inc.: Revenue, 2018-2020, $ bn	89

List Of Figures:

Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030	16
Figure 4. North America Injectable Drugs Market, 2019-2030, $ bn	19
Figure 5. Impact of COVID-19 on Business	23
Figure 6. Primary Drivers and Impact Factors of North America Injectable Drugs Market	25
Figure 7.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	28
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060	28
Figure 9. Primary Restraints and Impact Factors of North America Injectable Drugs Market	30
Figure 10. Investment Opportunity Analysis	34
Figure 11. Porter’s Fiver Forces Analysis of North America Injectable Drugs Market	37
Figure 12. Breakdown of North America Injectable Drugs Market by Molecule Type, 2019-2030, % of Revenue	42
Figure 13. North America Addressable Market Cap in 2021-2030 by Molecule Type, Value ($ bn) and Share (%)	42
Figure 14. North America Injectable Drugs Market by Molecule Type: Small Molecule, 2019-2030, $ bn	43
Figure 15. North America Injectable Drugs Market by Molecule Type: Large Molecule, 2019-2030, $ bn	44
Figure 16. Breakdown of North America Injectable Drugs Market by Drug Class, 2019-2030, % of Sales Revenue	46
Figure 17. North America Addressable Market Cap in 2021-2030 by Drug Class, Value ($ bn) and Share (%)	46
Figure 18. North America Injectable Drugs Market by Drug Class: Monoclonal Antibodies (mAbs), 2019-2030, $ bn	47
Figure 19. North America Injectable Drugs Market by Drug Class: Immunoglobulin, 2019-2030, $ bn	48
Figure 20. North America Injectable Drugs Market by Drug Class: Insulin, 2019-2030, $ bn	49
Figure 21. North America Injectable Drugs Market by Drug Class: Vaccines, 2019-2030, $ bn	50
Figure 22. North America Injectable Drugs Market by Drug Class: Cytokines, 2019-2030, $ bn	51
Figure 23. North America Injectable Drugs Market by Drug Class: Peptide Hormone, 2019-2030, $ bn	52
Figure 24. North America Injectable Drugs Market by Drug Class: Blood Factors, 2019-2030, $ bn	53
Figure 25. North America Injectable Drugs Market by Drug Class: Other Drug Classes, 2019-2030, $ bn	54
Figure 26. Breakdown of North America Injectable Drugs Market by Delivery, 2019-2030, % of Sales Revenue	56
Figure 27. North America Addressable Market Cap in 2021-2030 by Delivery, Value ($ bn) and Share (%)	56
Figure 28. North America Injectable Drugs Market by Delivery: Pre-filled Syringe, 2019-2030, $ bn	57
Figure 29. North America Injectable Drugs Market by Delivery: Infusions, 2019-2030, $ bn	58
Figure 30. North America Injectable Drugs Market by Delivery: Other Deliveries, 2019-2030, $ bn	59
Figure 31. Breakdown of North America Injectable Drugs Market by Application, 2019-2030, % of Revenue	61
Figure 32. North America Addressable Market Cap in 2021-2030 by Application, Value ($ bn) and Share (%)	61
Figure 33. North America Injectable Drugs Market by Application: Oncology, 2019-2030, $ bn	62
Figure 34. North America Injectable Drugs Market by Application: Infectious Diseases, 2019-2030, $ bn	63
Figure 35. North America Injectable Drugs Market by Application: Autoimmune Diseases, 2019-2030, $ bn	64
Figure 36. North America Injectable Drugs Market by Application: Cardiovascular Diseases, 2019-2030, $ bn	65
Figure 37. North America Injectable Drugs Market by Application: Pain, 2019-2030, $ bn	66
Figure 38. North America Injectable Drugs Market by Application: Neurology, 2019-2030, $ bn	67
Figure 39. North America Injectable Drugs Market by Application: Other Applications, 2019-2030, $ bn	68
Figure 40. Breakdown of North America Injectable Drugs Market by Distribution Channel, 2019-2030, % of Revenue	70
Figure 41. North America Addressable Market Cap in 2021-2030 by Distribution Channel, Value ($ bn) and Share (%)	70
Figure 42. North America Injectable Drugs Market by Distribution Channel: Hospital Pharmacy, 2019-2030, $ bn	71
Figure 43. North America Injectable Drugs Market by Distribution Channel: Retail Pharmacy, 2019-2030, $ bn	72
Figure 44. North America Injectable Drugs Market by Distribution Channel: E-Commerce, 2019-2030, $ bn	73
Figure 45. Breakdown of North America Injectable Drugs Market by Country, 2019 and 2030, % of Revenue	75
Figure 46. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%)	76
Figure 47. U.S. Injectable Drugs Market, 2019-2030, $ bn	78
Figure 48. Canada Injectable Drugs Market, 2019-2030, $ bn	80
Figure 49.  Injectable Drugs Market in Mexico, 2019-2030, $ bn	82
Figure 50. Growth Stage of North America Injectable Drugs Industry over the Forecast Period	84

Key Players (this may not be a complete list and extra companies can be added upon request): 
Amgen Inc.
Baxter International Inc.
Eli Lilly and Company
Gilead Sciences Inc.
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Moderna, Inc.
Novartis AG
Novo Nordisk AS
Pfizer Inc.
Sanofi SA
Teva Pharmaceuticals Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)